Early detection and intervention of psychosis. A review

Nordic Journal of Psychiatry

Volumn 62, Issue 2, 2008, Pages 92-105

  Salokangas, Raimo K R ^a   McGlashan, Thomas ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b YALE UNIVERSITY   (United States)

Author keywords

Basic symptoms; Early detection; Early intervention; Prodomal syndromes; Vulnerability to psychosis

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; DOPAMINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; RISPERIDONE;

ALCOHOL ABUSE; ANXIETY; BIPOLAR DISORDER; BRIEF PSYCHOTIC DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; DEPRESSION; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG EFFICACY; DRUG TOLERABILITY; EARLY DIAGNOSIS; EARLY INTERVENTION; FAMILY HISTORY; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HELP SEEKING BEHAVIOR; HIGH RISK PATIENT; HUMAN; LOW DRUG DOSE; NEUROPSYCHOLOGICAL TEST; PATIENT COUNSELING; PATIENT SATISFACTION; PERSONALITY DISORDER; PSYCHOEDUCATION; PSYCHOSIS; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SCHIZOTYPAL PERSONALITY DISORDER; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

EARLY DIAGNOSIS; HUMANS; PROGNOSIS; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 46749129769     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.1080/08039480801984008     Document Type: Review

References (165)

1. Knapp, MRJ, Almond, S. and Percudani, M. (1999) Costs of schizophrenia, a review. Schizophrenia, pp. 407-454. John Wiley & Sons, Chichester
2. Knapp, M., Mangalore, R. and Simon, J. (2003) The global costs of schizophrenia. Schizophr Bull, 30, pp. 279-293.
3. Joukamaa, M., Heliovaara, M., Knekt, P., Aromaa, A., Raitasalo, R. and Lehtinen, V. (2001) Mental disorders and cause-specific mortality. Br J Psychiatry, 179, pp. 498-502.
4. Kelly, C., McCreadie, RG, MacEwan, T. and Carey, S. (1998) Nithsdale schizophrenia surveys. 17. Fifteen year review. Br J Psychiatry, 172, pp. 513-517.
5. Johnstone, EC, Crow, TJ, Johnson, AL and Macmillan, JF. (1986) The Northwick Park study of first episodes of schizophrenia: I. Presentation of the illness and problems relating to admission. Br J Psychiatry, 148, pp. 115-120.
6. Hafner, H., Maurer, K., Loffler, W. and Riecher-Rossler, A. (1993) The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry, 162, pp. 80-86.
7. Larsen, TK, Johannessen, JO and Opjordsmoen, S. (1998) First-episode schizophrenia with long duration of untreated psychosis. Br J Psychiatry, 172, pp. 45-52.
8. Hafner, H., Loffler, W., Maurer, K., Hambrecht, M. and an der Heiden, W. (1999) Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiat Scand, 100, pp. 105-118.
9. Davidson, M., Reichenberg, A., Rabinpwitz, J., Weiser, M., Kaplan, Z. and Mark, M. (1999) Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry, 156, pp. 1328-1335.
10. Crow, TJ, MacMillan, JF, Johnson, AL and Johnstone, EC. (1986) A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry, 148, pp. 120-127.
11. Helgason, L. (1990) Twenty years' follow up of first psychiatric presentation for schizophrenia: What could have been prevented?. Acta Psychiatr Scand, 81, pp. 231-235.
12. Loebel, AD, Lieberman, JA, Alvir, JM, Mayerhoff, DI, Geisler, SH and Szymanski, SR. (1992) Duration of psychosis and outcome in first episode schizophrenia. Am J Psychiatry, 149, pp. 1183-1188.
13. Edwards, J., Maude, D., McGorry, PD, Harrigan, SM and Cocks, JT. (1998) Prolonged recovery in first-episode psychosis. Br J Psychiatry Suppl, 172, pp. 107-116.
14. Marshall, M., Lewis, S., Lockwood, A., Drake, R., Jones, P. and Croudace, T. (2005) Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Arch Gen Psychiatry, 62, pp. 975-983.
15. Perkins, DO, Gu, H., Boteva, K. and Lieberman, JA (2005) Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. Am J Psychiatry, 162, pp. 1785-1804.
16. Keshavan, MS, Haas, G., Miewald, J., Montrose, DM, Reddy, R. Schooler, NR et al. (2003) Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr Bull, 29, pp. 757-769.
17. Lappin, JM, Morgan, K., Morgan, C., Hutchison, G., Chitnis, X. Suckling, J. et al. (2006) Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res, 83, pp. 145-153.
18. Parnas, J. (1999) From predisposition to psychosis: Progression of symptoms in schizophrenia. Acta Psychiatr Scand; 99 Suppl, 395, pp. 20-29.
19. Meehl, PE. (1962) Schizotaxia, schizotypy, schizophrenia. Am Psychol, 17, pp. 827-838.
20. Bleuler, E. (1911) International University Press, New York
21. Yung, AR and McGorry, PD. (1996) The prodromal phase of first episode psychosis: Past and current conceptualizations. Schizophr Bull, 22, pp. 353-370.
22. McGorry, PD and Singh, BS. (1995) Schizophrenia: Risk and possibility. Handbook of preventive psychiatry, pp. 492-514. Elsevier, New York
23. Gottesman, II. (1991) Schizophrenia genesis: The origin of madness, Freeman, New York
24. Kendler, KS and Diehl, SR (1993) The genetics of schizophrenia: A current, genetic-epidemiologic perspective. Schizophr Bull, 19, pp. 261-285.
25. Asherson, P., Mant, R. and McGuffin, P. (1995) Genetics and schizophrenia. Schizophrenia, pp. 253-274. Blackwell Science, Cambridge
26. Gottesman, II. (1994) Schizophrenia epigenesis: Past, present, and future. Acta Psych Scand, 90, pp. 26-33.
27. Tienari, P., Wynne, LC, Moring, J., Lahti, I., Naarala, M. Sorri, A. et al. (1994) The Finnish adoptive family study of schizophrenia. Implications for family research. Br J Psychiatry, 23, pp. 20-26.
28. Siira, V., Wahlberg, KE, Miettunen, J., Tienari, P. and Laksy, K. (2006) Differentiation of adoptees at high versus low genetic risk for schizophrenia by adjusted MMPI indices. Eur Psychiatry, 21, pp. 245-250.
29. Olin, SS, John, RS and Mednick, SA. (1995) Assessing the predictive value of teacher reports in a high risk sample for schizophrenia: A ROC analysis. Schizophr Res, 16, pp. 53-66.
30. Olin, SS, Mednick, SA, Cannon, T., Jacobsen, B., Parnas, J. Schulsinger, F. et al. (1998) School teacher ratings predictive of psychiatric outcome 25 years later. Br J Psychiatry, 172, pp. 7-13.
31. Owens, DG, Miller, P., Lawrie, SM and Johnstone, EC. (2005) Pathogenesis of schizophrenia: A psychopathological perspective. Br J Psychiatry, 186, pp. 386-393.
32. Johnstone, EC, Ebmeier, KP, Miller, P., Owens, DG and Lawrie, SM. (2005) Predicting schizophrenia: Findings from the Edinburgh High-Risk Study. Br J Psychiatry, 186, pp. 18-25.
33. Owens, DG and Johnstone, EC. (2006) Precursors and prodromata of schizophrenia: Findings from the Edinburgh High Risk Study and their literature context. Psychol Med., 36, pp. 1501-1514.
34. Glatt, SJ, Stone, WS, Faraone, SV, Seidman, LJ and Tsuang, MT. (2006) Psychopathology, personality traits and social development of young first-degree relatives of patients with schizophrenia. Br J Psychiatry, 189, pp. 337-345.
35. Jones, P., Rodgers, B., Murray, R. and Marmot, MG. (1946) Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet, 344, pp. 1398-1402.
36. Jones, PB and van Os, JJ (1997) Predicting schizophrenia in teenagers: Pessimistic results from the British 1946 birth cohort.p. 11.
37. Salokangas, RKR. (2001) Precursors and markers of psychosis-Scientific basis for examinations and intervention. Neurol Psychiat Brain Res, 9, pp. 105-126.
38. Hultman, CM, Sparen, P., Takei, N., Murray, RM and Cnattingius, S. (1999) Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: Case-control study. BMJ, 318, pp. 421-426.
39. Dalman, C., Allebeck, P., Cullberg, J., Grunewald, C. and Koster, M. (1999) Obstetric complications and the risk of schizophrenia: A longitudinal study of a national birth cohort. Arch Gen Psychiatry, 56, pp. 234-240.
40. van Os, J., Hanssen, M., Bijl, RV and Vollebergh, W. (2001) Prevalence of psychotic disorder and community level of psychotic symptoms: An urban-rural comparison. Arch Gen Psychiatry, 58, pp. 663-668.
41. van Os, J., Pedersen, CB and Mortensen, PB. (2004) Confirmation of synergy between urbanicity ja familial liability in the causation of psychosis. Am J Psychiatry, 161, pp. 2312-2314.
42. Holloway, J., Hutchinson, G., Leff, JP, Mallett, RM, Harrison, GL, Murray, RM and Jones, PB. (2006) Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: Findings from the 3-center AeSOP study. Arch Gen Psychiatry, 63, pp. 250-258.
43. Selten, JP, Veen, N., Feller, W., Blom, JD, Schols, D. Camoenie, W. et al. (2001) Incidence of psychotic disorders in immigrant groups to The Netherlands. Br J Psychiatry, 178, pp. 367-372.
44. Hjern, A., Wicks, S. and Dalman, C. (2004) Social adversity contributes to high morbidity in psychoses in immigrants-A national cohort study in two generations of Swedish residents. Psychol Med, 34, pp. 1025-1033.
45. Kirkbridge, JB, Fearon, P., Morgan, C., Dazzan, P., Morgan, K. Tarrant, J. et al. (2006) Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: Findings from the 3-center AeSOP study. Arch Gen Psychiatry, 63, pp. 250-258.
46. Leao, TS, Sundquist, J., Frank, G., Johansson, LM, Johansson, SE and Sundquist, K. (2006) Incidence of schizophrenia or other psychoses in first- and second-generation immigrants: A national cohort study. J Nerv Ment Dis, 194, pp. 27-33.
47. Geddes, JR and Lawrie, SM. (1995) Obstetric complications and schizophrenia: A meta-analysis. Br J Psychiatry, 167, pp. 786-793.
48. Hafner, H., Maurer, K., Ruhrmann, S., Bechdolf, A., Klosterkotter, J. Wagner, M. et al. (2004) Early detection and secondary prevention of psychosis: Facts and visions. Eur Arch Psychiatry Clin Neurosci, 254, pp. 117-128.
49. Maki, P., Veijola, J., Jones, PB, Murray, GK, Koponen, H. Tienari, P. et al. (2005) Predictors of schizophrenia - A review. Br Med Bull, 73, pp. 1-15.
50. Yung, Y., Phillips, LJ, Cotton, S., Yung, AR, Francey, SM Yuen, HP et al. (2005) Obstetric complications and transition to psychosis in an "ultra" high risk sample. Aust N Z J Psychiatry, 39, pp. 460-466.
51. Jones, PB and Done, DJ. (1997) From birth to onset: A developmental perspective of schizophrenia in two national birth cohorts. Neurodevelopment and adult psychopathology, pp. 119-136. Cambridge University Press, Cambridge
52. Cannon, M., Jones, P., Huttunen, MO, Tanskanen, A., Huttunen, T. Rabe-Hesketh, S. et al. (1999) School performance in Finnish children and later development of schizophrenia: A population-based longitudinal study. Arch Gen Psychiatry, 56, pp. 457-463.
53. Rantakallio, P., Jones, P., Moring, J. and von Wendt, L. (1997) Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: A 28-year follow-up. Int J Epidemiology, 26, pp. 837-843.
54. David, AS, Malmberg, A., Brandt, L., Allebeck, P. and Lewis, G. (1997) IQ and risk for schizophrenia: A population-based cohort study. Psychol Med, 27, pp. 1311-1323.
55. Gunnell, D., Harrison, G., Rasmussen, F., Fouskakis, D. and Tynelius, P. (2002) Associations between premorbid intellectual performance, early-life exposures and early-onset schizophrenia. Cohort study. Br J Psychiatry, 181, pp. 298-305.
56. Beiser, M., Erickson, D., Fleming, JAE and Iacono, WG. (1993) Establishing the onset of psychotic illness. Am J Psychiatry, 150, pp. 1349-1354.
57. Meehl, PE. (1990) Toward an integrated theory of schizotaxia, schizotypy and schizophrenia. J Pers Dis, 4, pp. 1-99.
58. Hoch, PH, Cattel, JP, Strahl, MO and Pennes, HH. (1962) The course and outcome of pseudoneurotic schizophrenia. Am J Psychiatry, 119, pp. 106-115.
59. Salokangas, RKR (1977) Skitsofreniaan sairastuneiden psykososiaalinen kehitys.
60. Salokangas, RKR (1985) Skitsofrenian hoito ja ennuste.
61. Nordentoft, M., Thorup, A., Petersen, L., Ohlenschlaeger, J., Malau, M. Ostergaard, C. et al. (2006) Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophr Res, 82, pp. 29-40.
62. Lewis, G., David, AS, Malmberg, A. and Allebeck, P. (2000) Non-psychotic psychiatric disorder and subsequent risk of schizophrenia. Cohort study. Br J Psychiatry, 177, pp. 416-420.
63. Weiser, M., Reichenberg, A., Rabinowitz, J., Kaplan, Z., Mark, M. Bodner, E. et al. (2001) Association between nonpsychotic psychiatric diagnoses in adolescent males and subsequent onset of schizophrenia. Arch Gen Psychiatry, 58, pp. 959-964.
64. Reihenberg, A. and Goldenberg, J. (2006) Self-reported mentl health difficulties and subsequent risk for schizophrenia in females: A 5-year follow-up cohort study. Schizophr Res, 82, pp. 233-239.
65. Salokangas, RKR Psychosocial prognosis in schizophrenia.
66. Hafner, H., Riecher-Rossler, A., Hambrecht, M., Maurer, K., Meissner, S. Schmiedtke, A. et al. (1992) IRAOS: An instrument for the assessment of onset of early course of schizophrenia. Schizophr Res, 6, pp. 209-223.
67. Hafner, H. and Maurer, K. (1991) Are there two types of schizophrenia? True onset and sequence of positive and negative syndromes prior to the first admission. Negative versus positive schizophrenia, pp. 134-159. Springer, Berlin
68. Hafner, H., Maurer, K., Trendler, G., an der Heiden, W, Schmidt, M. and Konnecke, R. (2005) Schizophrenia and depression: Challenging the paradigm of two separate diseases-A controlled study of schizophrenia, depression and healthy controls. Schizophr Res, 77, pp. 11-24.
69. Hafner, H. and Maurer, K. (2006) Early detection of schizophrenia. Current evidence and future perspectives. World Psychiatry, 5, pp. 130-138.
70. Chapman, JP. (1966) The early symptoms of schizophrenia. Br J Psychiatry, 112, pp. 225-251.
71. Kapur, S. (2003) Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry, 160, pp. 13-23.
72. Selten, JP and Cantor-Graae, E. (2005) Social defeat: Risk factor for schizophrenia?. Br J Psychiatry, 187, pp. 101-102.
73. McGorry, PD, McFarlane, C., Patton, GC, Bell, R., Hibbert, ME Jackson, H. et al. (1995) The prevalence of prodromal features of schizophrenia in adolescence: A preliminary survey. Acta Psychiatr Scand, 92, pp. 241-249.
74. Hanssen, MS, Bijl, RV, Vollebergh, W. and van Os, J. (2003) Self-reported psychotic experiences in the general population: A valid screening tool for DSM-III-R psychotic disorders?. Acta Psychiatr Scand, 107, pp. 369-377.
75. Poulton, R., Caspi, A., Moffitt, TE, Cannon, M., Murray, R. and Harrington, H. (2000) Children's self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study. Arch Gen Psychiatry, 57, pp. 1053-1058.
76. Cannon, M., Caspi, A., Moffitt, TE, Harrington, H., Taylor, A. Murray, RM et al. (2002) Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: Results from a longitudinal birth cohort. Ach Gen Psychiatry, 59, pp. 449-456.
77. Rossler, W., Riecher-Rossler, A., Angst, J., Murray, R., Gamma, A. Eich, D. et al. (2007) Psychotic experiences in the general population: A twenty-year prospective community study. Schizophr Res, 92, pp. 1-14.
78. van Os, J., Verdoux, H., Maurice-Tison, S., Gay, B., Liraud, F. Salamon, R. et al. (1999) Self-reported psychosis-like symptoms and the continuum of psychosis. Soc Psychiatry Psychiatr Epidemiol, 34, pp. 459-463.
79. Hafner, H., Nowotny, B., Loffler, W., an der Heiden, W and Maurer, K. (1995) When and how does schizophrenia produce social deficits?. Eur Arch Psychiatry Clin Neurosci, 246, pp. 17-28.
80. Hafner, H. and an der Heiden, W. (2003) Course and outcome of schizophrenia. Schizophrenia, pp. 101-141. Blackwell, London
81. Jablensky, A. (2003) The epidemiological horizon. Schizophrenia, pp. 203-231. Blackwell, London
82. Goldberg, T., David, A. and Gold, JM. (2003) Neurocognitive deficits in schizophrenia. Schizophrenia, pp. 168-184. Blackwell, London
83. Larsen, TK, McGlashan, TH, Johannessen, JO and Vibe-Hansen, L. (1996) First-episode schizophrenia: II. Premorbid patterns by gender. Schizophr Bull, 22, pp. 257-269.
84. MacEwan, TH and Athawes, RWB. (1997) The nithsdale schixophrenia surveys XV. Social adjustment in schizophrenia: Associations with gender, symptoms and childhood antecedents. Acta Psychiatry Scand, 95, pp. 254-258.
85. McGlashan, TH, Miller, TJ, Woods, SW, Hoffman, RE and Davidson, L. (2001) Instrument for the assessment of prodromal symptoms and states. Early intervention in psychotic disorders, pp. 135-149. Kluwer Academic, Dordrecht
86. Salokangas, RKR, Heinimaa, M., Huttunen, J., Klosterkotter, J., Ruhrmann, S. von Reventlow, H. et al. Quality of life in psychiatric patients vulnerable to psychosis. Results of the EPOS study. Presentaion in the 14th AEP Congress
87. Yung, AR, Buckby, JA, Cotton, SM, Cosgrave, EM, Killackey, EJ Stanford, C. et al. (2006) Psychotic-like experiences in nonpsychotic help-seekers: Associations with distress, depression, and disability. Schizophr Bull, 32, pp. 352-359.
88. Amminger, GP, Leicester, S., Yung, AR, Phillips, LJ, Berger, GE Francey, SM et al. (2006) Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals. Schizophr Res, 84, pp. 67-76.
89. Woods, S. Effects of Olanzapine in those at high risk of psychosis. Presentation in an international conference London "The early phase of psychosis-Research and treatment"
90. Goldberg, TE and Gold, JM. (1995) Neurocognitive deficits in schizophrenia. Schizophrenia, pp. 146-162. Blackwell Science, Cambridge
91. Lawrie, SM (1999)pp. 129-144. Cambridge University Press, Cambridge
92. Roitman, SE, Cornblatt, BA, Bergman, A., Obuchowski, M., Mitropoulou, V. Keefe, RS et al. (1997) Attentional functioning in schizotypal personality disorder. Am J Psychiatry, 154, pp. 655-660.
93. Franke, P., Maier, W., Hain, C. and Klingler, T. (1992) Wisconsin Card Sorting Test: An indicator of vulnerability to schizophrenia?. Schizophr Res, 6, pp. 243-249.
94. Cornblatt, BA and Keilp, JG. (1994) Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull, 20, pp. 31-46.
95. Bryne, M., Hodges, A., Grant, E. and Johnstone, EC. (1998) Evidence for executive dysfunction in young people at high genetic risk for schizophrenia? Results of the Hayling Sentence Completion Test. Schitzophr Res, 29, p. 43.
96. Toulopoulou, T., Morris, RG and Murray, RM. (1998) Spatial working memory and strategy formation in schizophrenic patients and their first degree relatives. Schitzophr Res, 29, p. 138.
97. Cannon, TD, van Erp, TGM, Finklestein, JRJ, Huttunen, M., Kaprio, J. Lonnqvist, J. et al. (1999) Disturbance in a frontal lobe-working memory circuit as an inherited neurobiological substrate in schizophrenia: Results from a controlled twin study. Schizophr Res, 36, p. 88.
98. Byrne, M., Hodges, A., Grant, E., Owens, DC and Johnstone, EC. (1999) Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: Preliminary findings of the Edinburgh High Risk Study (EHRS). Psychol Med, 29, pp. 1161-1173.
99. Finklestein, JRJ, Cannon, TD, Huttunen, T., Tuulio-Henrikson, A., Kaprio, J. Lonnqvist, J. et al. (1999) The viability of attention deficit as markers of genetic vulnerability to schizophrenia: A discordant twin study. Schizophr Res, 36, p. 90.
100. Egan, MF, Goldberg, TE, Gscheidle, T., Bigelow, L. and Weinberger, DR. (2000) Hereditability estimates for independent domains of cognitive dysfunction in schizophrenia. Schizophr Res, 41, pp. 89-90.
101. Trandafir, A., Meary, A., Schurhoff, F., Leboyer, M. and Szoke, A. (2006) Memory tests in first-degree adult relatives of schizophrenic patients: A meta-analysis. Schizophr Res, 81, pp. 217-226.
102. Cornblatt, B. (1999) High-risk research: Implications for new interventions. Plenary presentation, International Congress on Schizophrenia Research
103. Meurice, EE. (1998) Rorschach "Schizophrenia" Signs in healthy first degree family members of patients with schizophrenia. A study of three complete families. Schitzophr Res, 29, pp. 59-60.
104. Perry, W., Minassian, A., Cadenhead, K., Sprock, J. and Braff, D. (2003) The use of the Ego Impairment Index across the schizophrenia spectrum. J Pers Assess, 80, pp. 50-57.
105. Ilonen, T. (2005) Is it possible to differentiate patients vulnerable to psychosis?. Presentation at the XVIII International Congress of Rorschach and Projective Methods
106. Klosterkotter, J., Schultze-Lutter, F., Steinmeyer, EM and Wieneke, A. (1998) Are self-experienced neuropsychological deficits able to indicate liability to schizophrenia? Results of a comparative study of 1st-degree relatives of schizophrenics. Schitzophr Res, 29, p. 64.
107. Schulze-Lutter, F. Basic symptoms. Presentation in an international conference London "The early phase of psychosis-Research and treatment"
108. Bartok, E., Berecz, R., Glaub, T. and Degrell, I. (2005) Cognitive functions in prepsychotic patients. Prog Neuropsychopharmacol Biol Psychiatry, 29, pp. 621-625.
109. Tabraham, P., Brett, C., Johns, L., Valmaggia, L., Broome, M. Woolley, J. et al. (2006) Spatiel working memory is impaired in individuals at high risk for psychosis. Schizopr Res, 81, p. 271.
110. Pflueger, MO, Gschwandtner, U., Aston, J., Borgwardt, S. and Stieglitz, RD. (2006) The neuropsychological assessment of the risk for psychosis in the Basel FEPSY study. Eur Psychiatry, 21, p. S48.
111. Brewer, W., Francey, S., Yung, A., Velakoulis, D., Anderson, V. McGorry, P. et al. (1998) Cognitive and olfactory deficits: Course from high risk to first-episode psychosis. Schitzophr Res, 29, pp. 54-55.
112. Brewer, W., Francey, S., Yung, A., Velakoulis, D., Anderson, V. McGorry, P. et al. (1999) Cognitive and related olfactory deficits in young people at high risk for psychosis. Abstract of the 7th International Congress on Schizophrenia Research. Schizophr Res, 36, p. 125.
113. Brewer, WJ, Wood, SJ, McGorry, PD, Francey, SM, Phillips, LJ Yung, AR et al. (2003) Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry, 160, pp. 1790-1794.
114. Cornblatt, BA, Lencz, T., Smith, CW, Correll, CU, Auther, AM and Nakayama, E. (2003) The schizophrenia prodrome revisited: A neurodevelopment perspective. Schizophr Bull, 29, pp. 633-651.
115. Smith, CW, Park, S. and Cornblatt, B. (2006) Spatial working memory deficits in adolescents at clinical high risk for schizophrenia. Schizophr Res, 81, pp. 211-215.
116. Niendam, TA, Bearden, CE, Johnson, JK, McKinley, M., Loewy, R. O'Brien, M. et al. (2006) Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res, 84, pp. 100-111.
117. Francey, SM, Jackson, HJ, Phillips, LJ, Wood, SJ, Yung, AR and McGorry, PD. (2005) Sustained attention in young people at high risk of psychosis does not predict transition to psychosis. Schizophr Res, 79, pp. 127-136.
118. Wood, SJ, Berger, G., Velakoulis, D., Phillips, LJ, McGorry, PD Yung, AR et al. (2003) Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals. Schizophr Bull, 29, pp. 831-843.
119. Whyte, MC, Brett, C., Harrison, LK, Byrne, M., Miller, P. Lawrie, SM et al. (2006) Neuropsychological performance over time in people at high risk of developing schizophrenia and controls. Biol Psychiatry, 59, pp. 730-739.
120. Brewer, WJ, Francey, SM, Wood, SJ, Jackson, HJ, Pantelis, C. Phillips, LJ et al. (2005) Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry, 162, pp. 71-78.
121. Pantelis, C. Neuropsychological impairments in the At Risk Mental State. Presentation in an international conference London "The early phase of psychosis-Research and treatment"
122. Andreasson, S., Allbeck, P., Engstrom, A. and Rydberg, U. (1987) Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet, 2, pp. 1483-1486.
123. Arseneault, L., Cannon, M., Witton, J. and Murray, RM. (2004) Causal association between cannabis and psychosis: Examination of the evidence. Br J Psychiatry, 184, pp. 110-117.
124. Henquet, C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R. Wittchen, HU et al. (2005) Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ, 330, p. 11.
125. Caspi, A., Moffitt, TE, Cannon, M., McClay, J., Murray, R. Harrington, H. et al. (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biol Psychiatry, 57, pp. 1117-1127.
126. Hambrecht, M. and Hafner, H. (1996) Substance abuse and the onset of schizophrenia. Biol Psychiatry, 40, pp. 1155-1163.
127. Huber, G. (1966) Reine Defektsyndrome und Basisstadien endogener Psychosen. Fortschr. Neurol Psychiatry, 34, pp. 409-426.
128. Huber, G. (1968) Verlaufsprobleme schizophrenen Erkrankungen. Schweiz Arch Neurol Neurochir Psychiatry, 101, pp. 346-368.
129. Huber, G., Gross, G., Schuttler, R. and Linz, M. (1980) Longitudinal studies of schizophrenic patients. Schizophr Bull, 6, pp. 592-605.
130. Gross, G. and Huber, G. (1998) Prodromes and primary prevention of schizophrenic psychoses. Neurol Psychiatry Brain Res, 6, pp. 51-58.
131. Gross, G., Huber, G., Klosterkotter, J. and Linz, M. (1987) BSABS Bonner Skala fur die Beurtailung von Basissymptomen (Bonn Scale for the Assessment of Basic Symptoms), Springer, Manual, Kommentar, Dokumentationbogen. Berlin
132. Klosterkotter, J., Hellmich, M., Steinmeyer, EM and Schultze-Lutter, F. (2001) Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry, 58, pp. 158-164.
133. Bechdolf, A., Wagner, M., Veith, V., Pukrop, R., Berning, J. Stamm, E. et al. (2006) A randomized controlled trail of cognitive-behavioral therapy in the early initial prodromal state of psychosis. Schizophr Res, 81, pp. 22-23.
134. Comprehensive Assessment of At Risk Mental States (CAARMS) (1996)
135. Yung, AR, Phillips, LJ, McGorry, PD, McFarlane, CA, Francey, S. Harrigan, S. et al. (1998) Prediction of psychosis: A step towards indicated prevention of schizophrenia. Br J Psyschiatry, 172, pp. 14-20.
136. Yung, AR and Jackson, HJ. (1999) The onset of psychotic disorder: Clinical and research aspects. The recognition and management of early psychosis. A preventive approach, pp. 27-50. Cambridge University Press, Cambridge
137. Yung, AR, Stanford, C., Cosgrave, E., Killackey, E., Phillips, L. Nelson, B. et al. (2006) Testing the ultra high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res, 84, pp. 57-66.
138. Yung, AR, Yuen, HP, McGorry, PD, Phillips, LJ, Kelly, D. Dell'Olio, M. et al. (2005) Mapping the onset of psychosis: The Comprehensive Assessment of At-Risk Mental States. Aust NZ J Psychiatry, 39, pp. 964-971.
139. Miller, TJ, McGlashan, TH, Lifshey Rosen, J, Somjee, L., Markovich, PJ Stein, K. et al. (2002) Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: Preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry, 159, pp. 863-865.
140. Miller, TI, McGlashan, TH, Woods, SW, Stein, K., Driesen, N. Concran, CM et al. (1999) Symptom assessment in schizophrenic prodromal states. Psychiat Q, 70, pp. 273-287.
141. Woods, S. (2006) Presentation in an international conference "The early phase of psychosis-Research and treatment", pp. 3-4. London
142. Miller, TJ, McGlashan, TH, Rosen, JL, Cadenhead, K., Ventura, J. McFarlane, W. et al. (2003) Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: Predictive validity, interrater reliability, and training to reliability. Schizophr Bull, 29, pp. 703-715.
143. Phillips, LJ, Yung, A. and McGorry, PD (2000) Identification of young people at risk of psychosis: Validation of the Personal Assessment and Crisis Evaluation Clinic intake criteria. Aust N Zeal J Psychiatry, 34, pp. 164-169.
144. Yung, AR, Phillips, LJ, Yuen, HP and McGorry, PD. (2004) Risk factors for psychosis in an ultra high-risk group: Psychopathology and clinical features. Schizophr Res, 67, pp. 131-142.
145. McGorry, PD, Yung, AR, Phillips, LJ, Yuen, HP, Francey, S. Cosgrave, EM et al. (2002) Randomised controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Ach Gen Psychiatry, 59, pp. 921-928.
146. Morrison, AP, French, P., Walford, L., Lewis, SW, Kilcommons, A. Green, J. et al. (2004) Cognitive therapy for the prevention of psychosis in people at ultra-high risk. Randomised controlled trial. Br J Psychiatry, 185, pp. 291-297.
147. McGlashan, TH, Zipursky, RB, Perkins, DO, Addington, J., Woods, SW Miller, TJ et al. (2004) Olanzapine vs. placebo for prodromal schizophrenia. Schizophr Res, 67
148. Mason, O., Startup, M., Halpin, S., Schall, U., Conrad, A. and Carr, V. (2004) Risk factors for transition to first episode psychosis among individuals with "at-risk mental states". Schizophr Res, 71, pp. 227-237.
149. Broome, RM, Woolley, JB, Johns, LC, Valmaggia, LR, Tabraham, P. Gafoor, R. et al. (2005) Outreach and support in south London (OASIS): Implementation of a clinical service for prodromal psychosis and the at risk mental state. Eur Psychiatry, 20, pp. 372-378.
150. McGlashan, TH. (1998) Early detection and intervention of schizophrenia: Rationale and research. Br J Psychiatry, 172, pp. 3-6.
151. Jablensky, A. (2000) Prevalence and incidence of schizophrenia spectrum disorders: Implications for prevention. ANZ J Psychiatry, 34, pp. S26-S34.
152. McGrath, J. (2000) Universal interventions for primary prevention of schizophrenia. Aust NZ J Psychiatry, 34, pp. S58-S64.
153. Warner, R. (2001) The prevention of schizophrenia: What interventions are safe and effective?. Schizophr Bull, 27, pp. 551-562.
154. Mojtabai, R., Malaspina, D. and Susser, E. (2003) The concept of population prevention: Application to schizophrenia. Schizophr Bull, 29, pp. 791-801.
155. McGlashan, TH, Zipursky, RB, Perkins, DO, Addington, J., Miller, TJ Woods, SW et al. (2006) Randomized, double-blind trial of Olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry, 163, pp. 790-799.
156. Woods, SW, Breier, A., Zipursky, RB, Perkins, DO, Addington, J. Miller, TJ et al. (2003) Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry, 54, pp. 453-464.
157. Ruhrmann, S., Schulze-Lutter, F., Maier, W. and Klosterkotter, J. (2005) Pharmacological intervention in the initial prodromal phase of psychosis. Eur Psychiatr, 20, pp. 1-6.
158. Ruhrmann, S., Hoppmann, B., Theyshn, S., Picker, H., Kuhn, K-U Schulze-Lutter, F. et al. (2006) Acute symptomatic treatment clinically at risk for psychosis. Schizophr Res, 86, p. S8.
159. Keri, S., Kelemen, O. and Janka, Z. (2006) Therapy of mental states at high risk for psychosis: Preliminary results from Hungary (in Hungarian) Orv Hetil, 147, pp. 201-204.
160. Walsh, BC, Tully, E., Thomas, L., McGlashan, TH and Woods, S. (2006) Aripiprazole treatment of the psychosis prodrome. Schizophr Res, 86, p. S7.
161. Tsuang, MT, Stone, WS, Tarbox, SI and Faraone, SV. (2002) An integration of schizophrenia with schizotypy: Identification of schizotaxia and implications for research on treatment and prevention. Schizophr Res, 54, pp. 169-175.
162. Chong, SA, Verma, SK and McGorry, P. (2003) Psychosis-A need for preemptive intervention?. Singapore Med J, 44, pp. 426-427.
163. Morrison, AP, French, P., Walford, L., Lewis, SW, Kilcommons, A. Green, J. et al. (2004) Cognitive therapy for the prevention of psychosis in people at ultra-high risk. Br J Psychiatry, 185, pp. 291-297.
164. Bechdolf, A., Wagner, M., Veith, V., Ruhrman, S., Janssen, B. Bottlender, R. et al. (2006) A randomized controlled multicentre trial of cognitive behavioral therapy in the early initial prodromal state of psychosis. Schizophr Res, 86, p. S8.
165. Hafner, H., Maurer, K., Ruhrmann, S., Bechdolf, A., Klosterkotter, J. Wagner, M. et al. (2004) Early detection and secondary prevention of psychosis: Facts and visions. Eur Arch Psychiatry Clin Neurosci, 254, pp. 117-128.